Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001214659-24-017008
Filing Date
2024-10-02
Accepted
2024-10-02 14:14:55
Documents
1
Period of Report
2024-03-09

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-67098.html 4/A  
1 PRIMARY DOCUMENT marketforms-67098.xml 4/A 5126
  Complete submission text file 0001214659-24-017008.txt   6661
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Issuer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AQUESTIVE THERAPEUTICS, INC. 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address
Jung Cassie (Reporting) CIK: 0001960154 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-38599 | Film No.: 241346475